Provided by Tiger Trade Technology Pte. Ltd.

Twist Bioscience Corp

139.00
-2.3800-1.68%
Post-market: 140.111.11+0.80%17:33 EDT
Volume:1.89M
Turnover:260.77M
Market Cap:8.72B
PE:-62.35
High:140.60
Open:139.99
Low:135.00
Close:141.38
52wk High:155.44
52wk Low:23.30
Shares:62.71M
Float Shares:61.76M
Volume Ratio:1.22
T/O Rate:3.06%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-2.2293
EPS(LYR):-1.2987
ROE:-29.59%
ROA:-13.09%
PB:19.55
PE(LYR):-107.03

Loading ...

Twist Bioscience price target raised to $110 from $80 at Leerink

TIPRANKS
·
Jul 16

Press Release: Twist Bioscience to Report Fiscal 2026 Third Quarter Financial Results on Monday, August 3, 2026

Dow Jones
·
Jul 15

Twist Bioscience Schedules Fiscal Q3 Earnings Release and Investor Call

Reuters
·
Jul 15

Twist Bioscience is Maintained at Buy by Canaccord Genuity

Dow Jones
·
Jul 14

Twist Bioscience price target raised to $120 from $90 at Canaccord

TIPRANKS
·
Jul 14

Movement Alert|Twist Bioscience Falls 5.18% in Regular Trading, Biotech Sector Broad Selloff Compounded by Insider Selling Plans

Market Focus
·
Jul 10

Movement Alert|Twist Bioscience Rises 5.5% in Regular Trading, Trading at $94.83

Market Focus
·
Jul 09

Movement Alert|Twist Bioscience Falls 5.38% in Regular Trading, Rating Downgrade Triggers Profit-Taking After Early Session Surge

Market Focus
·
Jul 07

Movement Alert|Twist Bioscience Rises 5.05% in Regular Trading, Evercore ISI Raises Price Target to $102

Market Focus
·
Jul 07

Twist Bioscience Cut to In-line from Outperform by Evercore ISI Group

Dow Jones
·
Jul 06

Evercore ISI Downgrades Twist Bioscience to In Line From Outperform, Price Target is $66

MT Newswires Live
·
Jul 06

Twist Bioscience Corp : Evercore Isi Cuts to in Line from Outperform; Raises Target Price to $102 from $66

THOMSON REUTERS
·
Jul 06

Coda Octopus Appoints Mark Kelly CFO Effective Aug. 3, 2026

Reuters
·
Jul 06

Is Twist Bioscience’s (TWST) New ATM Shelf Reshaping Its Capital Structure Or Just Adding Flexibility?

Simply Wall St.
·
Jun 30

Twist Bioscience is Maintained at Buy by Guggenheim

Dow Jones
·
Jun 29

Twist Bioscience SVP, Chief Legal Officer Dennis Cho Sells 14,205 Shares for $1.27 Million

Reuters
·
Jun 27

Movement Alert|Twist Bioscience Rises 5.41% in Regular Trading, Accelerating Beyond Investment Bank Target Price of $90

Market Focus
·
Jun 26

Movement Alert|Twist Bioscience Rises 6.12% in Regular Trading, Breaking Through Analyst $90 Target Price on Continued Rebound

Market Focus
·
Jun 25

Twist Bioscience is Maintained at Overweight by Barclays

Dow Jones
·
Jun 24

Movement Alert|Twist Bioscience Rises 5.2% in Regular Trading, Investment Bank Buy Rating at $90 Target Supports Recovery from Dilution Concerns

Market Focus
·
Jun 24